menin inhibitors in aml: mechanism of action, the current key data, and predicting efficacy
Published 1 month ago • 201 plays • Length 7:27Download video MP4
Download video MP3
Similar videos
-
1:40
the role of menin inhibitors in the treatment of aml
-
3:17
ziftomenib: mechanism of action and promising results in patients with kmt2ar or npm1m aml
-
2:01
the future of menin inhibitors in aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
1:14
promising novel agents in aml: menin inhibitors
-
0:59
menin inhibitors in aml: providing options for patients with npm1 mutation and kmt2a rearrangement
-
1:38
the potential of menin inhibitors in specific molecular subsets of aml & all
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
1:27
the role of menin inhibitors in the treatment of hr-mds and aml
-
1:22
the promise of menin inhibition in aml
-
2:04
hot topics in the aml space: menin inhibitors
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
5:17
covalent-101: investigating menin inhibition with bmf-219 for treating patients with r/r aml or all
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy